MedTrace Logo

ExtraVascular Implantable Cardioverter Defibrillator (EV ICD) Japan Study

NCT07091916 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2025-09-03

Study results available
· View outcomes & findings →

Summary

The study is designed to characterize the acute safety and performance of the EV ICD System for Japanese patients.

Conditions

  • Tachycardia
  • Ventricular Arrythmia

Interventions

DEVICE

Defibrillation using the Extravascular ICD

VT/VF induction attempted for defibrillation testing, as well as requisite electrical testing.

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-22
Primary Completion
2023-11-16
Completion
2025-01-23
FDA Device
Yes

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07091916 on ClinicalTrials.gov